Biotech: Pressemitteilungen - Kategorie - Seite 138

Biotech

Category / Pharmaceuticals & Biotech / Biotech


AtmanCo Files Its Consolidated Financial Results for the First Quarter of 2013 and Presents a Summary of Its Activities

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 05/30/13 -- AtmanCo Inc. ("AtmanCo" or the "Company") (TSX VENTURE: ATW) has filed its consolidated interim financial statements for the quart ...

Warnex Reports First Quarter 2013 Results

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 05/29/13 -- Warnex Inc. (TSX VENTURE: WNX.H)(NEX: WNX) ("Warnex") announced today financial results for the first quarter ended March 31, 2013.Q1-2013 hig ...

Alethia Biotherapeutics Announces Entry into Licensing and Research Agreements for its Inhibitor of EMT with IBC Generium

MONTREAL, CANADA and MOSCOW, RUSSIA: MONTREAL, CANADA and MOSCOW, RUSSIA -- (Marketwired) -- 05/29/13 -- Alethia Biotherapeutics Inc., a privately held biotechnology company focused on developing therapeutic monoclonal antibodies (mAb) ...

SCYNEXIS Gains Worldwide Rights to Novel Antifungal Compound

RESEARCH TRIANGLE PARK, NC: First Oral Glucan Synthase Inhibitor Ready to Enter Phase II Trials ...

Horizon Pharma Announces Receipt of Fifth U.S. Patent Allowance for DUEXIS(R)

DEERFIELD, IL: DEERFIELD, IL -- (Marketwired) -- 05/29/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that it has received a Notice of Allowance (NOA) from the United States Patent and Trademark Office ( ...

Kadmon Corporation to Present at the Jefferies 2013 Global Healthcare Conference

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 05/29/13 -- Kadmon Corporation, LLC, today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the Jefferies 2013 ...

Portola Announces Closing of Initial Public Offering and Over-Allotment Option Exercise

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 05/28/13 -- Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) announced today the closing of its initial public offering of 9,686,171 shares of its common stock ...

MethylGene to Present Mocetinostat Data at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/28/13 -- MethylGene Inc. (TSX: MYG) today announced that clinical data for mocetinostat, the spectrum selective histone deacetylase (HDAC) inhibitor, will be ...

Cellceutix to Present Poster on Novel Anti-Cancer Drug at Annual ASCO Meeting

BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 05/28/13 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to t ...

Theratechnologies Inc.: Information on Class Action Motion

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 05/27/13 -- Theratechnologies (TSX: TH) announced today that 121851 Canada Inc., the same petitioner who filed a motion in July 2010, filed a second motion of au ...

Functional Technologies Receives Extension of Creditor Protection Period

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/24/13 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") reports that the court has granted an extension, until June 12, ...

Announcements in Conjunction With Theratechnologies Annual Meeting

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/24/13 -- Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders, chaired by Paul Pommier, chairman of the board of Theratechnologies.A ...

Med BioGene Announces Warrant Exercises

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/24/13 -- Med BioGene Inc. (TSX VENTURE: MBI) today announced that 2,318,000 warrants and agents' warrants to purchase an equal number of commo ...

Cynapsus Therapeutics Reports First Quarter 2013 Financial Results and Recent Developments

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 05/23/13 -- Cynapsus Therapeutics Inc. (TSX VENTURE: CTH), developing the only non-injectable (i.e. sublingual) delivery of the only approved drug (apomorphine) ...

Jennerex Completes $21.6 Million Private Placement

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 05/23/13 -- Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class tar ...

Flamel Technologies Obtains Rights to Two Molecules of Trigger Lock Product Line

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 05/23/13 -- Flamel Technologies (NASDAQ: FLML) today announced that it has exercised its right to regain control of two drugs that use its Trigger Lock™ delivery te ...

Functional Technologies to Apply for Extension of Creditor Protection Period

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/22/13 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") reports that it intends to make court application for an extens ...

PENSRUS PENS Rocks the AMC Music Fest in Just 9 Days to Raise Awareness and Funding for ARTHROGRYPOSIS MULTIPLEX CONGENITA (AMC)

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 05/22/13 -- The countdown is on and the will kick off at 3:00pm on Saturday, June 1st at Killmeyer's Old Bavarria Inn on Staten Island. Joined by PENSRUS PENS, N ...


Seite 138 von 255:  « ..  137 138 139  140  141  142  143  144  145  146  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z